In search for alternatives to corticosteroids and cytostatic drugs, mild immunosuppressive drugs, like cyclosporin A (CsA) and tacrolimus, that target IL-2 expression have been investigated in several clinical trials and are now recommended as third-line treatments for AIH when first- and second-line treatments fail (39). This evidence concerns the gene IL2 and autoimmune hepatitis.